A recent ruling by the United States Court of Appeals for the Federal Circuit has reversed a lower court’s decision that Myriad Genetics’ composition of matter claims covering isolated DNA molecules were patent-ineligible products of nature “since the molecules as claimed do not exist in nature”. According to a press release by the American Civil
World Congress for Freedom of Scientific Research the bulletin Number 27, August 2011 Gene Patents Upheld in Myriad Appeal. The new ruling reverses the district court’s decision that Myriad’s composition of matter claims covering isolated DNA molecules were patent-ineligible products of nature under, “since the molecules as claimed do not exist in nature.” Read the
by Alessandro De Luca
by Alessandro De Luca
by Pietro Migliorati
